Phase I Study of HIV 1 Antigen Expanded Specific T Cell Therapy
Clinical trial NCT02208167 · COMPLETED
Trial details
- NCT number
- NCT02208167
- Sponsor
- University of North Carolina, Chapel Hill
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-07
- Primary completion
- 2017-01-19
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.